🚀 VC round data is live in beta, check it out!
GridAI Technologies Valuation Multiples
Discover revenue and EBITDA valuation multiples for GridAI Technologies and similar public comparables like Eli Lilly, Johnson & Johnson, AbbVie, Roche and more.
GridAI Technologies Overview
About GridAI Technologies
GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company’s programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.
Founded
2014
HQ
Employees
2
Website
Sectors
Financials (FY)
Market Cap
—
GridAI Technologies Stock Performance
GridAI Technologies has current market cap of —.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| — | — | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialGridAI Technologies Valuation Multiples
GridAI Technologies Financial Valuation Multiples
As of March 11, 2026, GridAI Technologies has market cap of —.
Equity research analysts estimate GridAI Technologies' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 |
|---|
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified GridAI Technologies Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
GridAI Technologies Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Eli Lilly | XXX | XXX | XXX | XXX | XXX | XXX |
| Johnson & Johnson | XXX | XXX | XXX | XXX | XXX | XXX |
| AbbVie | XXX | XXX | XXX | XXX | XXX | XXX |
| Roche | XXX | XXX | XXX | XXX | XXX | XXX |
| Novartis | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
GridAI Technologies M&A Activity
GridAI Technologies acquired XXX companies to date.
Last acquisition by GridAI Technologies was on XXXXXXXX, XXXXX. GridAI Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by GridAI Technologies
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialGridAI Technologies Investment Activity
GridAI Technologies invested in XXX companies to date.
GridAI Technologies made its latest investment on XXXXXXXX, XXXXX. GridAI Technologies invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by GridAI Technologies
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout GridAI Technologies
| When was GridAI Technologies founded? | GridAI Technologies was founded in 2014. |
| Where is GridAI Technologies headquartered? | GridAI Technologies is headquartered in United States. |
| How many employees does GridAI Technologies have? | As of today, GridAI Technologies has over 2 employees. |
| Is GridAI Technologies publicly listed? | Yes, GridAI Technologies is a public company listed on Nasdaq. |
| What is the stock symbol of GridAI Technologies? | GridAI Technologies trades under ENTO ticker. |
| When did GridAI Technologies go public? | GridAI Technologies went public in 2016. |
| Who are competitors of GridAI Technologies? | GridAI Technologies main competitors are Eli Lilly, Johnson & Johnson, AbbVie, Roche. |
| Is GridAI Technologies profitable? | No, GridAI Technologies is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.